Device Interventional Oncology

Sir-Spheres Microspheres

Payments companies reported to CMS as associated with Sir-Spheres Microspheres. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6.2Massociated payments (2023-2025)
2,902clinicians with associated payments
1company reporting

By year

2023 $1.8M
2024 $2.3M
2025 $2.1M

Payments reported as associated with Sir-Spheres Microspheres, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $4.8M
Diagnostic Radiology $755K
Medical Oncology $218K
Hematology & Oncology $129K
Surgery $87K
Radiation Oncology $28K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sir-Spheres Microspheres

These are the largest totals companies reported as associated with Sir-Spheres Microspheres. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ripal Gandhi Miami, FL Vascular & Interventional Radiology $774,202.33
Nima Kokabi Atlanta, GA Vascular & Interventional Radiology $608,252.31
Edward Lee Los Angeles, CA Vascular & Interventional Radiology $481,865.46
Navid Eghbalieh Los Angeles, CA Vascular & Interventional Radiology $318,051.32
Suvranu Ganguli Boston, MA Vascular & Interventional Radiology $272,482.05
Michael Cohn Hollywood, FL Vascular & Interventional Radiology $209,741.54
Peiman Habibollahi Houston, TX Vascular & Interventional Radiology $191,223.58
Jayson Brower Spokane, WA Vascular & Interventional Radiology $172,705.33
Farshid Dayyani Orange, CA Medical Oncology $172,114.31
Michael Doherty Jackson, TN Diagnostic Radiology $161,264.28

Prescribed Sir-Spheres Microspheres?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.